AI innovations look set to transform healthcare by facilitating precision medicine, improving diagnostic accuracy and ...

Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ...

Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...

A tool to integrate breast cancer transcriptomic datasets could help clinicians with more accurate diagnosis and better ...

Health secretary Wes Streeting has stressed that the NHS is “not on the table” in any US trade deal, and that it is “not up ...

Preoperative single-fraction stereotactic partial breast irradiation using GammaPod technology is associated with a promising ...

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

Where did Trump and Bill Clinton go? Were any flights out of Palm Beach International? The details might surprise you.

AI holds the promise of being a major boon to the NHS. But so far, we have not seen AI have the impact that it has promised.

The global PD-L1 biomarker testing market is on a strong growth trajectory, rising from USD 777.2 million in 2025 to USD 1,690.8 million by 2035, at a CAGR of 8.1% during the forecast period.PD-L1 ...

Elon Musk said Thursday that Verizon’s efforts to provide a critically needed upgrade to the FAA’s air traffic control system ...